1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one
C113H78F8N20O5 — CID 161027617
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one
1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one (PubChem CID 161027617) has the molecular formula C113H78F8N20O5 and a molecular weight of 1947.99 g/mol. Its IUPAC name is 1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one.
Molecular Properties
| Compound Name | 1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one |
|---|---|
| PubChem CID | 161027617 |
| Molecular Formula | C113H78F8N20O5 |
| Molecular Weight | 1947.99 g/mol |
| Exact Mass | 1946.63 |
| IUPAC Name | 1-(3,4-difluorophenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;1-(3,4-dimethylphenyl)-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one;bis(1-(4-fluoro-2-methylphenyl)-9-(1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one);1-[4-fluoro-3-(trifluoromethyl)phenyl]-9-(4-methylimidazol-1-yl)benzo[h][1,6]naphthyridin-2-one |
| SMILES | Cc1cc(F)ccc1-n1c(=O)ccc2cnc3ccc(-c4cn[nH]c4)cc3c21.Cc1cc(F)ccc1-n1c(=O)ccc2cnc3ccc(-c4cn[nH]c4)cc3c21.Cc1cn(-c2ccc3ncc4ccc(=O)n(-c5ccc(C)c(C)c5)c4c3c2)cn1.Cc1cn(-c2ccc3ncc4ccc(=O)n(-c5ccc(F)c(C(F)(F)F)c5)c4c3c2)cn1.Cc1cn(-c2ccc3ncc4ccc(=O)n(-c5ccc(F)c(F)c5)c4c3c2)cn1 |
| InChI | InChI=1S/C24H20N4O.C23H14F4N4O.C22H14F2N4O.2C22H15FN4O/c1-15-4-6-20(10-16(15)2)28-23(29)9-5-18-12-25-22-8-7-19(11-21(22)24(18)28)27-13-17(3)26-14-27;1-13-11-30(12-29-13)15-4-6-20-17(8-15)22-14(10-28-20)2-7-21(32)31(22)16-3-5-19(24)18(9-16)23(25,26)27;1-13-11-27(12-26-13)15-4-6-20-17(8-15)22-14(10-25-20)2-7-21(29)28(22)16-3-5-18(23)19(24)9-16;2*1-13-8-17(23)4-6-20(13)27-21(28)7-3-15-10-24-19-5-2-14(9-18(19)22(15)27)16-11-25-26-12-16/h4-14H,1-3H3;2-12H,1H3;2-12H,1H3;2*2-12H,1H3,(H,25,26) |
| InChIKey | TZEUCWCPKWHTRE-UHFFFAOYSA-N |
| XLogP | 22.91 |
| TPSA | 285.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 23 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 146 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1947.99 |
| LogP ≤ 5 | 22.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 23 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161027617 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.